The average selling price for SENSIA in South Korea dropped in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the SENSIA device in South Korea can be viewed in GlobalData’s micro pricing report. Buy the report here.
The SENSIA is sold by Medtronic in the Dual Chamber Pacemaker market. Dual chamber pacemakers deliver energy to the heart muscle through wires called leads. The leads carry the electric impulse from the pacemaker to the heart and relay information about the heart’s natural activity back to the pacemaker. One lead paces the atrium and one paces the ventricle. This approach more closely mathches the natural pacing of the heart. These types of pacemaker can co-ordinate function between the atria and ventricles.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.
For a complete picture of Medtronic’ Dual Chamber Pacemaker device pricing in South Korea, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.